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Transmissible spongiform encephalopathies (TSEs or 
priori diseases) such as Creutzfeldt-Jakob disease and 
kuru in man or scrapie in sheep presented and still pres- 
ent major challenges to biomedical research. The first 
phase of investigation of these diseases was dominated 
by experiments at the biological level and led to the 
discovery of transmissibility, the existence of strains, as 
well as the peculiar properties of the transmissible 
agent, such as lack of immunogenicity and very long 
incubation times. The unusual resistance to radiation 
led to the proposal that the agent, or prion, might be 
devoid of nucleic acid (in this paper we will use the term 
prion to signify infectious TSE agent, regardless of its 
composition or structure). The next phase, in which we 
and our colleagues at the Institute of Molecular Biology 
of Z0rich University participated, initially in collaboration 
with Stan Prusiner and his colleagues, saw the isolation 
and biochemical characterization of PrP s~ and PrP c 
(Oesch et al., 1985), followed by the cloning of the PrP 
gene (Basler et al., 1986), and the establishment of ge- 
netic linkage between it and familial prion disease (Hsiao 
et al., 1989). In the third phase, transgenic experimenta- 
tion strengthened the link between the PrP gene and 
susceptibility to prion disease by showing that the so- 
called species barrier could be overcome, at least in 
some cases, by introducing the PrP gene of the donor 
into the recipient (Prusiner et al., 1990). It also became 
clear that mice expressing PrP transgenes with particu- 
lar mutations acquired neurodegenerative diseases; 
however, with a possible exception (Telling et al., 1996), 
these were not transmissible. 
Since the mid 1960s, the nature of the transmissible 
agent has being continuously debated. Inasmuch as 
a virus is understood to consist of a protein-encased 
nucleic acid encoding some or all of its constituent pro- 
teins, the concept of a "slow" or "unconventional" virus 
lost support as intense efforts in many laboratories failed 
to identify a TSE-specific nucleic acid or even a nucleic 
acid long enough to encode a small protein (Riesner et 
al., 1993). Nonetheless, a valiant rear guard still clings 
to the idea that a virus, perhaps an endogenous virus 
whose nucleic acid would not score as extraneous, is 
responsible for TSEs (Chesebro, 1999; Manuelidis, 
2003). The virino hypothesis, which holds that the infec- 
tious agent consisted of an agent-specific nucleic acid 
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enveloped in a host-specified protein, was proposed to 
explain the lack of an immune response by the host as 
well as strain variation (Kimberlin, 1982). On the other 
hand, the biochemical inkage of the infectious agent 
and PrP s~, a protease-resistant, aggregated conforma- 
tional isomer of the normal host protein PrP c (Gabizon 
et al., 1988), and the linkage between the PrP gene, 
prion diseases, and susceptibility to prions provided 
support for an updated version of the "protein only" 
hypothesis (Griffith, 1967), namely, that the infectious 
agent is PrP sc that "multiplies" by catalyzing the conver- 
sion of PrP c into a likeness of itself (Prusiner, 1991). A 
further proposal (Weissmann, 1991) attempted to medi- 
ate between the two camps by suggesting that the con- 
version of PrP c to an abnormal conformer is indeed 
an essential pathogenic event, but that a small host- 
specified nucleic acid associated with PrP s~, the "co- 
prion," is a critical component required to modulate 
strain specificity. However, this "unified theory" only 
succeeded in unifying the two camps against itself. 
Toward the end of the 1980s, work by O. Smithies, 
M. Capecchi, M. L. Hooper, D. M. Melton, and A. Bradley 
had made it clear that gene knockout in the mouse was 
a feasible undertaking, so that we decided in 1988 to 
try and generate a PrP knockout mouse and tackle the 
basic question of whether PrP was essential for suscep- 
tibility to TSEs and propagation of prions. Michel Aguet, 
who had recently joined us as Associate Professor, un- 
dertook to acquire the necessary mouse technology, 
mostly from Horst Bluethmann at Hoffmann-LaRoche, 
and in 1989 one of us (H.B.), a first-year graduate stu- 
dent, started attempts to target the PrP gene in em- 
bryonal stem (ES) cells that had been donated by Rolf 
Kemler and Allan Bradley, along with much good advice. 
After several failed attempts, we finally concentrated 
our efforts on a deletion vector in which two thirds of 
the PrP coding region had been replaced by a neomycin 
resistance gene. Because at the time no counterselec- 
tion against ectopic insertion of the deletion vector was 
used, some 10,000 ES cell clones had to be screened 
until a single clone heterozygous for the targeting event 
was found. After implantation of more than thousand 
blastocysts injected with cells from this single clone, 
over a period of some 6 months, germline transmission 
by a chimeric offspring, derived from Bradley's AB1 ES 
cells, was finally achieved and resulted in a mouse het- 
erozygous for the PrP knockout allele. We might mention 
at this point that we had considerable doubts as to 
whether a homozygous PrP knockout mouse would be 
healthy or even viable, in view of the fact that the PrP 
gene was singular, present in all vertebrates examined, 
expressed already during embryonal development in al- 
most all tissues and mainly in the brain, which, as Woody 
Allen commented, is after all our second most important 
organ. It was therefore an exhilarating surprise when 
perfectly normal, homozygous PrP knockout offspring 
emerged from the matings. At that time we knew of only 
one widely conserved protein in vertebrates that could 
be absent without causing a deleterious phenotype, 
namely albumin, deleted as a consequence of natural 
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mutations in both rats and humans. Our finding was 
so surprising at the time that a photograph of the PrP 
knockout mice made the cover of the Nature issue con- 
taining our report (B0eler et al., 1992). Subsequently, 
discrete changes in electrophysiological properties 
(Collinge et al., 1994) and response to oxidative stress of 
cultured cells from knockout mice have been described 
(Brown et al., 2002), albeit without revealing the function 
of PrP c at the molecular level. 
As an aside, we should mention that a few years later, 
in contradiction to our findings and to our irritation, a 
Japanese group reported that their PrP knockout mice 
developed ataxia and cerebellar Purkinje cell loss as 
they aged (Sakaguchi et al., 1996) and that the pheno- 
type could be abrogated by introduction of PrP trans- 
genes. This discrepancy (Weissmann, 1996) was finally 
resolved by David Westaway and his colleagues (Moore 
et al., 1999). They showed that the pathological pheno- 
type of these mice was due to the extensive deletion 
introduced into their PrP genes, which unleashed a se- 
ries of complex events resulting in the accumulation of 
doppel, a protein normally absent from postnatal brain. 
Doppel proved to be toxic for cerebellar neurons and, 
surprisingly, its effects were counteracted by PrP (Moore 
et al., 1999). The lesson here is that knockouts can have 
unpredictable outcomes and that had the Japanese 
knockout been published first, it might well have been 
erroneously accepted that PrP is required for mainte- 
nance of cerebellar integrity (Weissmann and Aguzzi, 
1999). 
Intracerebral injection of our PrP knockout mice and 
their wild-type littermates with mouse-adapted scrapie 
prions was initiated as soon as sufficient mice were 
available. After some 6 months, all inoculated wild-type 
controls were dead of scrapie and, to our mounting 
excitement, mice devoid of PrP continued healthy week 
after week. Thirteen months after inoculation and follow- 
ing histopathological evaluation (carried out blind by 
Adriano Aguzzi), we felt safe in concluding that PrP 
knockout mice were completely resistant to disease. 
Equally important, after many bioassays, we concluded 
that there was no replication of prions (B0eler et al., 
1993; Sailer et al., 1994). Rarely, an inoculated mouse 
showed very low levels of infectivity, as subsequently 
also reported by others; this is generally attributed to 
residual inoculum, but it sewed as a trickle of water on 
the mills of the "protein only" antagonists (Chesebro 
and Caughey, 1993). Susceptibility to disease and ability 
to replicate prions were restored by the introduction of 
PrP transgenes and, in fact, even enhanced if PrP was 
overexpressed (B0eler et al., 1993). 
These experiments, showing that PrP was essential 
for prion propagation and pathogenesis, fulfilled a cen- 
tral prediction of the "protein only" hypothesis and sig- 
nificantly promoted its acceptance, although they by no 
means constituted proof. The virus-friendly rear guard 
explained our results by proposing that PrP was a virus 
receptor, while the virinophiles welcomed PrP as the 
host-specified coat of the hypothetical nucleic acid. 
As regards our current view of the structure of the 
infectious entity, it seems likely that a conformer of PrP c 
is an essential component; it is still not clear whether 
this is PrP sc, originally defined as a protease-resistant, 
aggregated form of PrP c (Meyer et al., 1986), or some 
other conformer, such as the somewhat oxymoronically 
designated "protease-sensitive PrP so'' (Safar et al., 1998; 
Tzaban et al., 2002). In vitro conversion of PrP c into a 
prpSc-like conformation, elicited by incubation with 
PrP s°, has been achieved; however, no increase in in- 
fectivity has been reported (Kocisko et al., 1994; Lucas- 
sen et al., 2003; Saborio et al., 2001). Failure, to date, 
to convert PrP c into an infectious form in a cell-free 
system argues against a straightforward conformational 
change; rather, other components may be required, 
either in a structural or catalytic role. Whether the so- 
called "yeast prions" and the seeding mechanism under- 
lying their replication provide a valid model for mamma- 
lian prions remains to be seen. The discovery of siRNAs 
and microRNAs, which would have escaped notice in 
previous analyses of prion preparations, both because 
of their size and their host origin, provides candidates 
for the hypothetical coprion and breathes a little life into 
the comatose "unified theory" mentioned above. 
Whatever the implications for the nature of the prion, 
the generation of PrP knockout mice paved the way to 
reverse genetics of PrP and allowed the delineation of 
PrP sequences essential for prion susceptibility. The 
introduction of foreign PrP genes into knockout mice 
abrogated the species barrier for bovine BSE and human 
sCJD prions, allowing a practical bioassay. PrP knock- 
out mice enabled the production of monoclonal anti- 
PrP antibodies that could never be made in PrP-tolerant 
wild-type mice (Prusiner et al., 1993). Tissue-specific 
expression of PrP in PrP knockout mice helped under- 
stand the spread of prions from the periphery to the CNS 
and their amplification in the lymphoreticular system. 
The generation of healthy PrP knockout mice provided 
the first example of disease-resistant animals generated 
by genetic engineering and suggested that healthy PrP 
knockout cattle and sheep, resistant o BSE and scrapie, 
respectively, might be generated and prove useful as 
a source of pharmaceutical products; ongoing efforts, 
however, have not yet been successful. Last but not 
least, inhibition of PrP accumulation or its sequestration 
from the cell surface by antibodies or drugs might pres- 
ent an approach to therapy of prion disease in humans, 
albeit one fraught with difficulties. 
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Summary 
Fractions purified from scrapie-infected hamster 
brain contain a unique protein, designated PrP. It 
was labeled with N-succinimidyl 3-(4-hydroxy-5- 
[~zsI]-iodophenyl) propionate, which did not alter the 
titer of the scrapie prion. The concentration of PrP 
was found to be directly proportional to the titer of 
the infectious prion. Both PrP and prion infectivity 
were resistant for 2 hr at 37°C to hydrolysis by 
proteinase K under nondenaturing conditions. Pro- 
longing the digestion resulted in a concomitant de- 
crease in both PrP and the scrapie prion. When the 
amino-acid-specific proteases trypsin or SV-8 pro- 
tease were used instead of proteinase K, no change 
in either PrP or the prion was detected. The parallel 
changes between PrP and the prion provide evi- 
dence that PrP is a structural component of the 
infectious prion. Our findings also suggest that the 
prion contains only one major protein, namely PrP. 
Introduction 
The scrapie agent causes a degenerative neurological 
disease of sheep and goats. The agent is prototypic of a 
novel class of infectious pathogens called prions (Prusiner, 
1982). Both kuru and Creutzfeidt-Jakob disease (CJD) of 
humans (Gajdusek, 1977) also may be caused by pdons. 
With the development of an effective partial purification 
scheme, convincing evidence was obtained for a protein 
within the scrapie agent (Prusiner, 1982; Prusiner et al., 
1980, 1981). The titer of the scrapie prion in partially 
purified fractions could be diminished both by proteolytic 
digestion (Prusiner et al., 1981) and by chemical modifi- 
cation with diethylpyrocarbonate (DEP) (McKinley et al., 
1981 ). 
Having shown that the infectivity of the scrapie agent 
depended upon a protein or proteins, we began to search 
for proteins that were unique to purified fractions of the 
agent. Using fractions derived from an improved purifica- 
tion procedure, we identified a protein, designated PrP, of 
apparent molecular weight 27,000 to 30,000, which was 
found in all purified scrapie pdon fractions, but was absent 
from control preparations (Prusiner et al., 1982a; Bolton et 
al., 1982). The native protein was resistant to hydrolysis 
catalyzed by proteases; however, denaturation by boiling 
in sodium dodecylsulfate (SDS) rendered PrP susceptible 
to enzymatic proteoiysis (Bolton et al., 1982). PrP could 
be labeled with 14C-DEP; earlier studies have shown that 
DEP reversibly inactivates the infectious prion (Bolton et 
al., 1982; McKinley et al., 1981). 
On the basis of these observations, we asked whether 
PrP is a component of the prion or a pathologic product 
of infection. Evidence presented here indicates that PrP is 
a component of the prion. PrP is the first structural molecule 
within the scrapie agent to be identified. Our observations 
also demonstrate that the prion contains only one major 
protein, namely PrP. We do not know how many, if any, 
minor proteins the prion may contain. 
Results 
When sucrose gradient fractions enriched for the scrapie 
agent were radioiodinated, PrP was found to be a predom- 
inant protein (Bolton et al., 1982). PrP was distinguished 
from normal brain proteins by its microheterogeneity (Mr 
27,000-30,000) during SDS polyacrylamide gel electropho- 
resis and by its resistance to protease digestion in the 
native or nondenatured state. Figure 1 illustrates a com- 
parison between purified scrapie and normal brain frac- 
tions after treatment with proteinase K. Though both sam- 
ples originally contained similar amounts of protein, pro- 
tease digestion under nondenaturing conditions hydro- 
lyzed all proteins in the normal brain fraction, but left PrP 
intact in the scrapie fraction. 
Although PrP has been found only in purified fractions 
from scrapie-infected brains, it is necessary to determine 
whether PrP is a structural component of the prion or a 
pathologic product of infection. Since denaturation of pur- 
ified samples prior to SDS gel electrophoresis resulted in 
a significant loss of titer, we could not determine if PrP 
eluted from SDS polyacrylamide gels is sufficient for 
expression of prion infectivity. We approached this prob- 
lem by asking whether the concentration of PrP is directly 
proportional to the titer of the infectious prion. 
A relationship between PrP and scrapie infectivity was 
observed in discontinuous sucrose gradients used for 
obtaining our purified preparations of prions. To quantitate 
this relationship, the amount of radioiodinated PrP in gra- 
dient fractions was determined by scanning autoradi- 
ograms of electrophoretic gels with a laser densitometer. 
A correlation between the prion titer (IDs0 units/ml) and PrP 
concentration (units/ml) over nearly a 100-fold range was 
found in fractions I through 5 from the bottom of a sucrose 
gradient (Figure 2A). To verify this relationship between 
infectivity and PrP, aliquots of fractions from three other 
preparative sucrose gradients were radioiodinated and 
held at 37°C for 30 min either with or without 100 p~g/ml 
of proteinase K. The aliquots were then electrophoresed 
into SDS polyacrylamide gels. The correlation between 
prion infectivity and PrP was confirmed in both undigested 
(Figure 213) and protease-digested samples (Figure 2C). 
Although the results from these three gradients show a 
greater scatter of the data than was observed in the initial 
study, the same relationship between titer and protein 
concentration appears to hold. 
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Summary 
S. B. Prusiner proposed that the infectious agent of 
scrapie, the prion, is PrP s~, a modified form of the nor- 
mal host protein PrP c. Prn-p °~° mice devoid of PrP c 
showed normal development and behavior. When in- 
oculated with mouse scrapie prions, they remained 
free of scrapie symptoms for at least 13 months while 
wild-type controls all died within 6 months. Surpris- 
ingly, heterozygous Prn-p °~* mice also showed en- 
hanced resistance to scrapie, After introduction of Syr- 
ian hamster PrP transgenes, Prn-p °~° mice became 
highly susceptible to hamster but not to mouse prions. 
These experiments how that PrP c, possibly at close 
to normal levels, is required for the usual susceptibility 
to scrapie and that lack of homology between incom- 
ing prions and the host's PrP genes retards disease. 
Introduction 
The nature of the prion, the agent causing transmissible 
spongiform encephalopathies uch as scrapie in animals 
or Creutzfald-Jakob disease in humans, has been a long- 
standing enigma. Considerable evidence has accumu- 
lated in support of Prusinefs proposal (Prusiner, 1982), 
subsequently espoused by others (Bolton, 1988; Bolton 
and Bendheim, 1988; Gajdusek, 1991), that the prion con- 
sists of PrP so, a modified form of the normal host protein 
PrP c, and is devoid of nucleic acid (the "protein only" 
model; for reviews see Prusiner, 1991; Weissmann, 1991). 
The propagation of the prion is thought o come about by 
the conversion of endogenous PrP c to PrP s~ catalyzed by 
PrP s~ (Prusiner, 1991; Prusiner et al., 1990). 
There are two major lines of evidence in favor of the 
protein only hypothesis. First, PrP s~ and scrapie infectivity 
copurify by several procedures (Bolton et al., 1982; Dir- 
inger et al., 1983; Prusiner et al., 1982, 1983), including 
affinity chromatography on an anti-PrP monoclonal anti- 
body column (Gabizon et al., 1988), and no scrapie- 
specific nucleic acid has been detected in highly purified 
prion preparations, despite long-standing efforts (Oesch et 
al., 1988; Meyer et al., 1991; Kellings et al., 1992). Second, 
genetic evidence points to an intimate linkage between 
prion disease and Pro-p, the gene for PrP. Thus, Prn-i, a 
host gene codetermining incubation time for scrapie (most 
likely identical to Sinc) (Carlson et al., 1986; Hunter et al., 
1987), is closely linked if not congruent to Prn-p (Carlson 
et al., 1986; Hunter et al., 1987; Carlson et al., 1988, 1989; 
Race et al., 1990). Furthermore, a seminal experiment 
by Prusiner and his colleagues showed that the species 
barrier (Pattison, 1966) to prion transmission from hamster 
to mouse could be overcome by introducing a Syrian ham- 
ster PrP transgene into the recipient mouse line (Scott et 
al., 1989). Even more significantly, the prions generated 
in such transgenic mice were hamster specific when the 
prion inoculum was hamster derived and mouse specific 
when it was mouse derived (Prusiner et al., 1990). Another 
strong argument in favor of the protein only hypothesis 
was the seminal discovery of Hsiao et al. (1989), confirmed 
and extended by others (reviewed by Baker and Ridley, 
1992), which led to the realization that in most, if not all, 
cases of the human familial spongiform encephalopathies 
occurrence of the disease is linked to mutations in the 
PrP gene. 
Nonetheless, some workers believe that the scrapie 
agent is but an unconventional, nucleic acid--containing 
virus and that the accumulation of PrP s~ is secondary, 
reflecting a consequence of infection and cell damage (Dir- 
inger et al., 1988; Manuelidis et al., 1988; Rohwer, 1991; 
Kimberlin, 1990). 
If indeed PrP s~ is an essential component of the scrapie 
agent, then mice devoid of PrP should be resistant o infec- 
tion, developing neither symptoms of scrapie nor allowing 
propagation of the infectious agent. Conversely, if the ani- 
mals succumb to the disease or propagate infectivity, al- 
beit without showing symptoms of neurological disease, 
the protein only hypothesis would be falsified. 
We have reported eadier on the generation of mice ho- 
mozygous for disrupted Prn-p genes (Pm-p °~° mice) and 
have shown that although no PrP is detectable in the 
brains of these animals, they develop and reproduce nor- 
mally and show no detectable physical or behavioral de- 
fect (BOeler et al., 1992). It thus became possible to study 
the response of Pm-p °~° mice to inoculation with scrapie 
prions, as well as of animals carrying a single Pm-p allele 
(Pm-p °~÷ mice) and of Pm-p °~° mice reconstituted with Syr- 
ian hamster PrP genes, 
Results 
Challenge of Prn.p~O Mice with Scrapie Prions 
Both the mice homozygous for the wild-type and the dis- 
rupted Prn-p genes had a genetic background derived 
from 129/Sv and C57BL/6J animals. Fifty-seven each of 
Prn-p °~° and Prn-p ÷1÷ mice were inoculated intracerebrally 
with a high dose (about 107 LDs0 units) of the Chandler 
isolate of mouse-adapted prions (Chandler, 1961). As a 
further control, 13 Swiss CD-1 mice, a strain commonly 
used for the titration of mouse prions (Eklund et al., 1967), 
were inoculated in the same fashion. Four animals of each 
group (one animal only in the case of CD-1 mice) were 
